Chemotherapy for Poor Risk Germ Cell Tumours An Independent Evaluation of the POM B/ACE Regime
- 1 November 1988
- journal article
- research article
- Published by Wiley in British Journal of Urology
- Vol. 62 (5), 454-460
- https://doi.org/10.1111/j.1464-410x.1988.tb04396.x
Abstract
We have evaluated the 7-drug, alternating, high-dose cisplating regime for germ cell tumours, designated POMB/ACE, in 55 patients with advanced malignant teratomas and 5 patients with bulky metastatic seminomas. All of the latter and 5 of the teratomea patients had relapsed following radiotherapy, chemotherapy or both. The previously untreated teratoma patients included 13 whose tumours were extragonadal. The primary testicular tumour patients compared 16 with large and 21 with very large volume metastases according to the Medical Reserach Council criteria. POMB/ACE is effective therapy for poor risk patients with germ cell tumours (including those with the most advanced disease, i.e., hepatic and cerebral metastases) and prolonged treatment after marker normality seems unnecessary. It is a complex region with significantly toxicity and cannot be recommended for the treatment of patients with germ cell tumours who have an excellent prognosis with simpler, shorter and less toxic treatment.This publication has 10 references indexed in Scilit:
- Have new aggressive chemotherapy regimens improved results in advanced germ cell tumors?European Journal of Cancer and Clinical Oncology, 1986
- Cisplatin neuropathy with Lhermitte's sign.Journal of Neurology, Neurosurgery & Psychiatry, 1986
- Successful management of metastatic and primary germ cell tumors in the brainCancer, 1986
- Current Optimum Management of Anaplastic Germ Cell Tumours of the Testis and Other SitesBritish Journal of Urology, 1986
- Five-year survival of patients with disseminated nonseminomatous testicular cancer treated with cisplatin, vinblastine, and bleomycinCancer, 1984
- FURTHER ADVANCES IN THE MANAGEMENT OF MALIGNANT TERATOMAS OF THE TESTIS AND OTHER SITESThe Lancet, 1983
- Chemotherapy of advanced malignant teratomasBritish Journal of Cancer, 1980
- COMBINED MANAGEMENT OF MALIGNANT TERATOMA OF THE TESTISThe Lancet, 1979
- Cis-Diamminedichloroplatinum, Vinblastine, and Bleomycin Combination Chemotherapy in Disseminated Testicular CancerAnnals of Internal Medicine, 1977
- Combination chemotherapy in germinal cell tumorsCancer Treatment Reviews, 1976